NGT HealthCare II ("NGT") is an early-stage medical device and life sciences venture capital fund, investing in promising technologies. The fund focuses on creating value and investing in people with innovative ideas. A significant risk reduction mechanism is achieved through non-dilutive leverage via Israel’s Innovation Authority (IIA). NGT leverages close relationships with leading universities, hospitals, and research institutions in Israel to gain access to a rich flow of investment opportunities. A wide network with multinational corporations enables NGT to create value for its portfolio companies. NGT is structured as an impact fund, located in Nazareth, and aligned with 3 UN SDGs. The fund aims to expand its network and explore new opportunities continuously.
Preferred startup development maturity for initial funding deployment.
Medical devices, life sciences
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...